ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

QDEL QuidelOrtho Corporation

39.64
-0.05 (-0.13%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
QuidelOrtho Corporation QDEL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.05 -0.13% 39.64 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
39.49 39.30 40.405 39.64 39.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202404:45PRNUSQuidelOrtho Corporation f/k/a Quidel Corporation Sued for..
19/4/202405:40PRNUSClass Action Filed Against QuidelOrtho Corporation f/k/a..
17/4/202406:00BWQuidelOrtho To Report First Quarter 2024 Financial Results
10/4/202406:00BWQuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a..
02/4/202408:00BWQuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue®..
06/3/202415:35BWQuidelOrtho Receives Health Canada Approval for Quidel®..
29/2/202415:40EDGAR2Form 8-K/A - Current report: [Amend]
29/2/202414:29EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202415:30BWQuidelOrtho to Participate in 45th Annual Raymond James..
21/2/202406:30EDGAR2Form 8-K - Current report
21/2/202406:30BWQuidelOrtho Announces Changes in Executive Leadership
16/2/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202406:00EDGAR2Form 8-K - Current report
13/2/202415:07EDGAR2Form 8-K - Current report
13/2/202415:05BWQuidelOrtho Reports Fourth Quarter and Full-Year 2023..
12/2/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202406:00BWQuidelOrtho to Report Fourth Quarter and Full-year 2023..
22/12/202306:00BWQuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare..
20/12/202315:05BWQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex..
08/12/202315:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/12/202315:40EDGAR2Form 8-K - Current report
16/11/202316:05BWQuidelOrtho to Participate in the Evercore ISI Conference
01/11/202315:12EDGAR2Form 8-K - Current report
01/11/202315:05BWQuidelOrtho Reports Third Quarter 2023 Financial Results
17/10/202314:43PRNUSPowerful Lyme Disease Awareness PSA Featuring Christopher..
12/10/202306:04EDGAR2Form 8-K - Current report
12/10/202306:00BWQuidelOrtho Reports Preliminary Revenue Results for the..
21/9/202315:05BWQuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+..
28/8/202315:05BWQuidelOrtho to Participate in the Morgan Stanley 21st Annual..
18/8/202315:06EDGAR2Form 8-K - Current report
08/8/202316:00EDGAR2Form 8-K - Current report
08/8/202315:30BWQuidelOrtho Reports Second Quarter 2023 Financial Results
25/7/202315:00BWQuidelOrtho Ranks No. 1 in Customer Satisfaction for Six..
25/7/202312:12BWQuidelOrtho Partners With BYG4lab® to Strengthen Informatics..
24/7/202314:00BWQuidelOrtho Partners With BYG4lab® to Strengthen Informatics..
18/7/202315:05BWQuidelOrtho to Report Second Quarter 2023 Financial Results
23/5/202306:00BWQuidelOrtho to Participate in William Blair 43rd Annual..
03/5/202315:05BWQuidelOrtho Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock